Avation Medical Revenue and Competitors

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Avation Medical's estimated annual revenue is currently $3.5M per year.(i)
  • Avation Medical's estimated revenue per employee is $116,667

Employee Data

  • Avation Medical has 30 Employees.(i)
  • Avation Medical grew their employee count by 3% last year.

Avation Medical's People

NameTitleEmail/Phone
1
Consulting CFOReveal Email/Phone
2
CEO & President, Co-Founder, Member Board DirectorsReveal Email/Phone
3
Sr. Director Clinical OperationsReveal Email/Phone
4
Chief Technology Officer and Co-FounderReveal Email/Phone
5
Chief Marketing OfficerReveal Email/Phone
6
Director Software DevelopmentReveal Email/Phone
7
Senior Director, Finance and Human ResourcesReveal Email/Phone
8
Project ManagerReveal Email/Phone
9
Senior Executive Assistant/Office ManagerReveal Email/Phone
10
Sr. Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M8311%N/AN/A
#2
$3.5M2568%N/AN/A
#3
$300M13038%N/AN/A
#4
$3.5M303%N/AN/A
#5
N/A3228%N/AN/A
#6
$3.5M704%N/AN/A
#7
$3.5M356%N/AN/A
#8
$3.5M11-21%N/AN/A
#9
$7.5M797%N/AN/A
#10
N/A5-29%N/AN/A
Add Company

What Is Avation Medical?

Avation Medical is pioneering new platforms for wearable nerve modulation systems. We are transcending peripheral nerve stimulation by developing powerful therapies designed to place the patient in control of their treatment. It’s neuromodulation re-imagined.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$3.5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avation Medical News

2022-04-13 - Avation Medical Announces Appointment of Chief Marketing Officer ...

COLUMBUS, Ohio, April 13, 2022 /PRNewswire/ -- Avation Medical, an innovative neuromodulation and digital health company pioneering a wearable...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.8M303%N/A
#2
$6.5M300%N/A
#3
$3.5M307%N/A
#4
$6M303%N/A
#5
$5.9M3025%N/A